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B  cells  display  distinct  patterns  of expression  of immunoglobulin  (Ig)  molecules 
that help to define their specific stage of development. The earliest  detectable cell in 
the  B  lineage  is  the  pre-B  cell.  It  expresses  no  surface  Ig  molecules  yet  possesses 
intracytoplasmic/1 heavy chains witho!lt light chains (sIg-, c/~  +) (1-4). B lymphocytes 
are  characterized  by  the  production  of heavy  and  light  chains  resulting  in  the 
assembly of monomeric Ig molecules that are detectable on the cell surface (sIg  +)  (5). 
These cells are capable of being triggered by antigen or mitogen to differentiate  into 
plasma cells that secrete large amounts of Ig but express very little surface Ig (2, 6, 7). 
It is now evident that, besides phenotypic differences found among B cells at various 
stages of differentiation,  the Ig heavy chain  molecule itself changes.  Although there 
is  still  some  controversy  (8-10),  the  membrane-associated  heavy  chain  appears  to 
possess an extra hydrophobic piece at  its carboxyterminus. This "tail"  is not present 
on heavy chains secreted by plasma cells, which migrate as slightly smaller molecules 
on polyacrylamide gels (11-13). The mRNA for these two proteins share the same 5' 
sequence.  Their  differences  have  been  attributed  to  alternative  mechanisms  of 
mRNA processing that result in two separate  3' sequences  (14,  15).  It is not yet clear 
whether  the heavy chain  found in pre-B cells  is similar to the membrane/~  ~m) 1 or 
secreted/1 ~).  Results demonstrating secretion by murine fetal liver and human bone 
marrow pre-B cells  (16)  suggest that the pre-B heavy chain is more closely related to 
/~ Ig heavy chains. However, messenger RNA for both/~s and ~n~ (2.4 kb and 2.7 kb) 
has been detected  in murine  fetal  liver pre-B cells  (4),  and both ~s and ~m proteins 
have been isolated from a  human pre-B cell line  (17). 
Recently,  tumors  and  lymphoblastoid  cell  lines  (LBL)  with  features  similar  to 
normal  B  cells  at  distinct  developmental  stages  have become available  (18).  These 
cells are useful for examining specific B cell characteristics and biosynthetic patterns 
because large quantities of a relatively pure population of cells can be obtained. While 
extrapolations  to normal cells must be done with great care, the use of LBL and cell 
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lines derived from B cell malignancies has permitted the generation of a large amount 
of data on  the biochemical properties of the different species of/~ heavy chains  (10, 
19, 20) and on the DNA sequences encoding the #  chain gene (21-23). However, very 
little information exists at the molecular level about the mechanisms controlling the 
synthesis of the various types of# heavy chain molecules during differentiation. 
Previous studies (24, 25) have demonstrated that the thymidine analogue, 5-bromo- 
2'-deoxyuridine (BUdR), can interfere with the expression of differentiation-specific 
cell  functions  without  affecting other  "housekeeping"  functions  (24,  25).  BUdR  is 
incorporated into the genome in place of thymidine (26)  and may interfere with the 
function of intermediately repetitive DNA sequences (27). We examined the effect of 
BUdR on Ig expression in several LBL. Our data indicate that BUdR very selectively 
inhibits the production of/Xm  and might allow increased production of/~ in surface 
Ig  + B  cell lines; #  chain production by "pre-B" and "plasma" cell lines is unaffected 
by BUdR  incorporation. 
Materials  and  Methods 
Cell Lines.  The cell lines used in this study possess phenotypes of B cells at various stages of 
development (Table I). Two lines, Nalm-6 and Daudi, were obtained from Dr. E. W. Ades (Eli 
Lilly Co., Indianapolis, IN), while others were transformed in this laboratory either sponta- 
neously or with Epstein-Barr virus (LBW 2,  6,  13,  14,  17, and  25)  (28,  29).  Cell lines were 
maintained in RPMI  1640 with  10% fetal bovine serum,  2 mM  L-glutamine, and 50/~g/ml 
gentamycin. Cultures were split every 2-4 d, depending on rate of growth. 
Incubation  with  BUdR.  5-bromo-2'-deoxyuridine (Calbiochem-Behring Co.,  La Jolla, CA) 
was added to cell cultures at doses ranging from 2.5 to 15/~g/ml for 2-6 d. Initial cell densities 
ranged  from  0.5-1.2  ×  106 cells/ml, which  usually permitted two cell divisions during the 
culture period. At the end of the culture period, cells were counted in a Coulter counter, and 
cell viability was determined by trypan blue dye exclusion. Care was taken to prevent direct 
exposure of cells to ultraviolet or fluorescent light. 
Antibody  Reagents and Fluorescent Staining.  Goat anti-human # chain and light chain reagents 
were affinity purified, as previously described (30).  Purity of reagents was determined by (a) 
Ouchterlony gel diffusion, (b) immunoeleetrophoresis, (c) fluorescent staining of specific human 
myeloma cells, and  (d)  enzyme-linked immunosorbent  assays. Conjugation of antibodies to 
fluorescein isothiocyanate and rhodamine isothiocyanate for surface and cytoplasmic staining 
were performed as indicated previously (30). Goat anti-human Drw antiserum was a gift from 
Dr. Marianne Egan (University of Alabama Medical Center, Birmingham, AL). 
Radioactive Labeling and Ig Isolation.  (a) Surface Ig were labeled with a25I by the lactoperoxidase 
method  (31,  32).  10  million cells were labeled, washed extensively with phosphate-buffered 
saline (PBS), and lysed with PBS containing 0.5%  sodium deoxycholate, 0.1%  Nonidet P-40, 
0.1%  NaNa,  1 mM phenylmethylsulfonylfluoride, 2 mM e-aminocaproic acid, and  1 mg/ml 
soybean trypsin inhibitor for 30  rain at room  temperature.  Cell lysates were sedimented at 
10,000 g for 20 rain. The 10,000 g supernatant was then centrifuged for 60 minutes at  100,000 
g. This 100,000 g supernatant was incubated with either goat anti-human/x, x, or ~  for 90 min 
at 4°C, then with 50 btl of a  10% suspension of fixed S. aureus Cowans I for 30 min at 4°C (33). 
The precipitate was washed extensively and then treated with sample buffer (20% glycerol, 4% 
sodium dodecyl sulfate (SDS), 0.12 M  Tris-HC1 pH 6.8, and 0.005%  bromphenol blue) in the 
presence or absence of 10% 2-mercaptoethanol. The eluted material was separated on 10% SDS- 
bis-acrylamide gels according to the method of Laemmli (34).  (b) Cells were biosynthetically 
35  labeled by adding 50 btCi of [  S]methionine and cysteine (600 Ci/mmole, Amersham, Arlington 
Heights, IL) to  1.0-1.5 ×  10  v control and BUdR-treated cells in  1 ml of RPMI  1640 lacking 
methionine and cysteine for 6 or 9 h. BUdR-treated cultures were maintained in BUdR during 
the labeling period. Cells were harvested, culture supernatants were saved, and cells were lysed 
as above. Ig was isolated from cell lysates and media and labeled material were analyzed by 
SDS-polyaerylamide gel eleetrophoresis (SDS-PAGE) as above. Gels were impregnated with 1624  REGULATION OF  MEMBRANE /~ OR  SECRETED ~t 
En~Hance (New England Nuclear, Boston, MA), washed, dried, and exposed to Kodak XAR- 
5 x-ray film (Eastman Kodak Co., Rochester, NY). 
Treatment of CeUs with Tunicamycin.  To distinguish nonglycosylated secretory and membrane 
/~ chains, cultures were treated with 2.5 p,g/ml tunicamycin (kindly provided by Dr. R. Hamill, 
Eli Lilly and Co., Indianapolis, IN) for 90 min before labeling, then continuously during the 
labeling period.  Ig was  isolated as above and analyzed after separation on 8  18%  SDS-bis- 
acrylamide gels. 
Quantitation of Ig.  Ig synthesis was quantitated by either of two methods. Radiolabeled cell 
lysates, culture supernatants, and surface labeled proteins were cleared and immunoprecipitated 
as described above and then counted in a Packard 3002 liquid scintillation counter. Nonspecific 
background radioactivity was subtracted from each sample. Alternatively, cells were analyzed 
by a quantitative enzyme-linked immunosorbent assay to determine the amount of surface and 
cytoplasmic/1 (35). 
Results 
Phenotypic Characterization of Cell Lines.  Each cell line displayed a  phenotype similar 
to normal cells at specific developmental stages (Table I). Nalm-6 is considered similar 
to pre-B cells because it produces cytoplasmic/~ chains without light chains and lacks 
surface  Ig  and  Fcy  receptors.  The  B  lymphocyte  phenotype  is  represented  by  five 
surface/1  + cell lines. Some members of this group  do not produce  light chains, even 
though they have lu on their surface and express cytoplasmic/t (L. Hendershot and D. 
Levitt, unpublished results). The plasma cell lines LBW- 17 and LBW-25 stain brightly 
for cytoplasmic/~ and light chain hut express scant amounts of IgM on their surface. 
These  cells  secrete  relatively  large  amounts  of pentameric  IgM  that  can  be  easily 
detected  by  both  biosynthetic  and  enzyme-linked  immunosorbent  assay  (ELISA) 
methods. 
Effect  of  BUdR  on  Ig  Phenotype.  When  either  pre-B  or  plasma  cell  lines  were 
incubated with  BUdR  (0-10 #g/ml)  for  3-6  d,  no effect  on Ig expression  could  be 
observed by immunofluorescence (Fig.  1). After 4  d  in culture with BUdR,  cell lines 
displaying surface/~ exhibited a  decrease  in the number of surface/~+ cells in a  dose- 
dependent manner  (Fig, 2). This reduction in surface expression of~ was observed in 
TABLE  I 
Characteristics of Lymphoblastoid Cell Lines 
Cell Line  Cytoplas-  Surface p~{  Light  mic ~*  chain*{  Secretion§  EcT{  Drw{ 
NALM-6  +  ..... 
LBW-2  ++  +  --  --  P  P 
LBW-14  ++  +  --  --  P  P 
DB  ++  ++  --  --  P  P 
LBW-6  ++  ++  ++  --  P  P 
LBW- 13  ++  +  +  --  P  P 
DAUDI  +  +++  +++  --  P  P 
LBW-17  +++  ±  +++  ++++  P  P 
LBW-25  +++  +_  +++  ++++  P  P 
* Cytoplasmic/~ and light chains were detected by fluorescent staining  of fixed cytocentrifuge 
preparations. 
:~ Presence of surface antigens was determined by fluorescent staining of intact viable cell 
suspensions. 
§ Secretion of IgM by cell lines was analyzed by quantitative ELISA. 
[I Antigen not detectable (--); dim to very bright (+- to ++++); P, antigen present. LINDA  HENDERSHOT  AND  DANIEL  LEVITT  1625 
NALM-6  DAUDI  LBW-2 
% c~ 50-  s/~+%  50  % st," 50 
25-  25  25 
3d  4d  5d  4d  3d  4d 
LBW-25  LBW-14  LBW-13 
:/~+ 50  % s~.  ÷ 50  % c~ 5o- 
25-  25  25 
3d  5d  3d  5d  4d  6d 
Fro.  1.  Effect of BUdR on  surface  and  cytoplasmic  expression  of #.  Lymphoblastoid  cell  lines 
were cultured  with  10 #g/ml  BUdR  for  3-6 d, as  noted.  Surface  #  was  detected  by  fluorescent 
staining of viable cells, and cytoplasmic # was observed by fluorescent staining of fixed cytocentrifuge 
preparations  of cultured  cells.  Both  surface  and  cytoplasmic  /z  are  expressed  as  the  number  of 




Days in  Culture 
Flo.  2.  Dose-response curve for BUdR effect. A surface #-positive B cell line, LBW-2, was cultured 
with 0  (A); 2.5  (A); 5 (0);  7.5 (O); and 10 (U) #g/ml BUdR for 2-6 d. Cells were harvested,  and 
surface/z was detected by fluorescent staining of viable cells with goat anti-human/z. 
all surface #+ lines regardless of the presence of light chains or cytoplasmic #  (Fig.  1). 
The loss of surface/z was dependent on cell division and could be blocked by adding 
equimolar or excess thymidine, but not by adding deoxycytidine (data not shown). 
Synthesis  of Ix  in  BUdR-treated  Cultures.  We  next  examined  Ig  and  total  protein 
synthesis in cells after 4 d of culture in the presence of BUdR. Total protein synthesis 
(measured  by the incorporation of [aSS]methionine and cysteine into trichloroacetic 
acid precipitable counts) was not affected by the incorporation of BUdR into cellular 
DNA in any of the cell lines examined (Table II). Immunoprecipitation of the labeled 
cell lysates and supernatants with anti-human/z showed no alteration of Ig synthesis 
or secretion in pre-B or plasma  cell  lines after  BUdR  treatment.  When  B  cell  lines 
were  examined,  we  found that, despite a  marked  decrease  in surface  Ig expression, 
total # synthesis was not significantly depressed and in some lines actually increased 
after BUdR incorporation (Table II). These findings were confirmed by quantitating 1626  REGULATION OF  MEMBRANE #  OR  SECRETED pt 
TABLE II 
Quantitat,on of Ig Synthesis by Radiolabeling and ELISA * 
Radiolabeling  ELISA 
cpm ass/106 cells  ng/z/10 n Ig  + cells 
Total protein~:  Cell-associated/z§  Totall[  Surface[[  Media[[ 
Nalm-6 
Control  0,5 x  10  6  1.7 X 10  a  98  --  -- 
BUdR  0.6 x  106  2.1 ×  103  95  --  -- 
LBW-2 
Control  7.8 X l06  6.3 X 104  150  47  10.2 
BUdR  8.4 X 106  7.2 X 104  164  20  9.2 
Daudi 
Control  6.4 ×  106  2.0 X 104  216  120  6.8 
BUdR  6.2 ×  10  ~  2.8 x  104  196  27  30.2 
LBW-17 
Control  3.3 ×  106  1.9 ×  l0  s  1,360  --  1,720 
BUdR  3.4 X l0 6  2.l X 10  ~  1,424  --  1,920 
* All values represent an average of three experiments. 
:~ Total protein synthesis  was determined by I0% trichloroacetic acid precipitation of labeled 
material from cell lysates. 
§ Cell-associated  IgM production was detected by immunoprecipitation of cell lysates after 
9 h. of labeling with [aSS]methionine  and cysteine. 
II IgM synthesis was quantitated  using the ELISA. Estimation of total cell-associated IgM 
was performed after lysing cells with detergent buffer. Surface Ig was calculated by an 
ELISA on intact viable cells. Quantitation of secretion was performed by analyzing day-4 
culture supernatants. 
total IgM using an ELISA (Table II). 
Effect  of BUdR  on Membrane  It.  Daudi cells display easily detectable surface IgM 
{#,  ~)  with little cytoplasmic IgM  and appear similar to  resting B  lymphocytes by 
immunofluorescent staining. When such  ceils were  treated  for  4  d  with  10  Itg/ml 
BUdR, the percentage of cells expressing surface IgM decreased, whereas an increase 
in the number of cells demonstrating cytoplasmic #  by fluorescent staining occurred 
(Table III). Surface ELISA demonstrated a  sixfold decrease in surface IgM but only 
a slight reduction in total IgM in BUdR-treated cultures (Table II). The loss of ability 
to synthesize or insert/zm was most pronounced after stripping surface proteins from 
control and BUdR-treated Daudi cells with pronase (1.5 mg/ml) (Table III). BUdR- 
treated cells failed to regenerate surface It,  whereas control cells reexpressed surface 
IgM within 24 h. The expression of two other surface proteins, Fcy receptor and Drw 
antigen, was not reduced qualitatively in BUdR-treated cultures. Unlike surface IgM, 
these proteins were regenerated after removal by pronase digestion on BUdR-treated 
cell surfaces (Table III), 
Reversibility  of BUdR Effects.  85% of Daudi cells failed to exhibit surface IgM after 
4  d  of culture with BUdR. When these cells were grown for 4  d  in the  absence of 
BUdR, the expression of surface/z reached control levels (81%).  Thus, it is unlikely 
that a BUdR-induced mutation is responsible for loss of surface IgM in B lymphocyte 
cell lines. 
SDS-PAGE  Analysis  of It  Chains  Produced  by  BUdR-treated  Cells.  Incorporation of 
BUdR had no effect on the size of It chain produced by two cell lines, Nalm-6 (pre-B 
like) and LBW-17 (plasma cell-like), as demonstrated by the isolation and separation 
of labeled bt chains on SDS-PAGE (Fig. 3). Both cell lines possess cytoplasmic ~t chains LINDA  HENDERSHOT  AND  DANIEL  LEVITT 
TABLE  III 
Expression  of Surface Markers by Control and BUdR-treated Cells after 
Pronase Treatment * 
Percent positive cells 
Surface/.t:~  Cytoplasmic  Drw~  FcT receptor:~ 
Control  90  6  99  99 
BUdR  38  12  96  99 
20 h after 
pronase 
Control  86  5  97  ~ 1 
BUdR  18  30  96  <1 
45 h after 
pronase 
Control  85  6  96  92 
BUdR  10  45  96  95 
* Surface markers were stripped by incubating cells in 1.5 mg/ml pronase for 
30 min. Cells were washed and allowed to regenerate surface markers.  Cells 
were examined for the expression  of surface markers directly after pronase 
treatment and were found to be negative. 
:~ Presence of surface antigens was determined by fluorescent staining of intact 
viable cell suspensions. 
§ Cytoplasmic/~ was detected by fluorescent  staining of fixed cytocentrifuge 
preparations, 
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Fro.  3.  lg synthesis by pre-B and plasma cell lines after treatment with BUdR. Nalm-6 and LBW- 
17 cells were cultured for 4 d with  10 ~g/ml BUdR. Control and BUdR-treated cells were then 
labeled with 50/~Ci [35S]methionine and cysteine for 9 h, and IgM was isolated from cell lysates and 
media. Precipitated material was reduced, alkylated, and separated on 10% SDS-PAGE. Lanes 1-4 
are # chains from lysates; lanes 5-6 are ~ chains from media. 
that  migrate slightly faster than  reduced/~ chains secreted from  LBW-17  or serum 
IgM standards. Because of the absence of surface/~ on either cell line, the secretion of 
large amounts  of pentemeric #  by LBW- 17  and an apparent  molecular weight of 73 1628  REGULATION OF  MEMBRANE /1 OR  SECRETED  /t 
kd for the ~  chains  isolated  from these cells, we are assuming that  the cytoplasmic 
chains found in these lines are precursors to ~s. 
IgM  produced  by  BUdR-treated  and  untreated  Daudi  cell  cultures  was  next 
analyzed  on  polyacrylamide  gels.  Separation  of 125I surface-labeled  ~  chains  from 
control cells revealed a  single strong band with  an apparent  molecular weight of 78 
kd,  but  only a  very faint  band could be isolated  from the  surface of BUdR-treated 
cells (Fig. 4). After biosynthetic labeling, two sizes of ~ chains were precipitated  from 
control  cultures  (78  kd  and  73  kd;  Fig.  4,  lane  3).  The  BUdR-treated  cultures 
synthesized significant quantities of only the smaller (73 kd) species of a/t (Fig. 4, lane 
4). When control cell lysates were incubated with anti-K, the 78 kd/~ was preferentially 
precipitated.  However,  anti-~  precipitation  of the  BUdR-treated  cell  lysate  clearly 
precipitated  the smaller  73 kd band,  demonstrating a  shift  in light chain association 
from the 78 kd/~ to the 73 kd ~ after BUdR treatment  (data not shown). 
Loss of Higher  Molecular Weight  tt  in  BUdR-treated  Cultures  Is  Not  Due  to  Altered 
Glycosylation.  It  has  recently  been  demonstrated  (11)  that  the  two  sizes  of bt chain 
isolated  from Daudi  cells represent  membrane  (higher mol wt)  and  secretory  (lower 
mol wt)/1. Because it is possible that the smaller tool wt/t band synthesized by BUdR- 
treated cells includes an underglycosylated precursor of ~,i~, we analyzed the produc- 
tion  of /t  chains  by  control  and  BUdR-treated  Daudi  cells  in  the  presence  of 
tunicamycin, an inhibitor of glycosylation (36). Control cultures continued to synthe- 
size two distinct sizes of/t chains, the unglycosylated precursors to ~m and ~s  (Fig.  5, 
lane  1).  BUdR-treated  cells  produced  only  the  smaller  (pre-secretory)  size /~  chain 
(Fig.  5, lane  2).  Therefore,  the  loss of surface/t  in  B  lymphoblastoid  cell  lines  after 
FIe. 4.  BUdR blocks  #m synthesis in B cell lines. 4-d cultures of control and BUdR-treated Daudi 
cells were either surface labeled with 12~I  by the lactoperoxidase method or biosynthetically labeled 
using 50 ttCi [aSS]methionine and cysteine. Cell lysates were immunoprecipitated with anti-human 
/t, reduced, alkylated, and separated on 10% SDS-PAGE./t chains from control (lane 1) and BUdR- 
treated (lane 2) cells after surface labeling./t chains from control (lane 3) and BUdR-treated  (lane 
4) cells after internal labeling. LINDA HENDERSHOT AND DANIEL LEVITT  1629 
BUdR treatment is due to the absence of membrane # production. 
Although no IgM could be precipitated  from control culture supernatants,  small 
quantities of IgM were isolated from BUdR-treated cells, suggesting that secretion by 
such cells is possible (data not shown). The # chain in IgM secreted by BUdR cells co- 
migrated with the IgM secreted by the LBW-17 plasma cell line. 
Discussion 
Using the thymidine analogue BUdR (26),  we developed a system to evaluate the 
regulation of/~ chain production in human lymphoblastoid cell lines.  Incorporation 
of BUdR into the DNA of pre-B like and plasma cell lines, which probably produce 
p~, failed to inhibit IgM synthesis. However, a clear, reproducible depression of surface 
bt ~Um) expression in B lymphoblastoid cell lines was apparent. This blockage occurred 
even while cytoplasmic/~ (/~) continued to be expressed in the same B cell line. 
Recent information indicates that secretory and membrane # chains differ in their 
primary structure  at  the carboxyterminus  (10,  11,  37).  The  two protein  molecules 
may share a single nuclear transcript that would then be processed differently at the 
3' end  (14).  It seemed unlikely that  incorporation of BUdR into the cellular  DNA 
altered  either transcription or translation of the #  chain gene, because both #s  and 
~m share the same 5' sequence (14,  38), and only membrane #  production is altered. 
Instead, it was postulated that either (a) BUdR prevented membrane/~ proteins from 
FIG. 5.  # chains produced by control and BUdR-treated B cells in the presence of tunicamycin. 
4-d  cultures of control and  BUdR-treated Daudi cells were preincubated with 2.5  /.tg/ml of 
tunicamycin for 90 min, then labeled with [35S]methionine and cysteine for 6 h. Cell lysates were 
immunoprecipitated with goat anti-human /.t, reduced, alkylated, and separated by 8-18% SDS- 
PAGE. 1630  REGULATION OF  MEMBRANE /~ OR SECRETED 
reaching the surface of B cells, or (b) it interfered with the processing of the membrane 
/~ chain message. 
Against  the  former hypothesis  (a)  we  found  that  the  expression  of other  surface 
proteins, e.g., Fc  T receptors and Drw antigens, was not altered on cells grown in the 
presence of BUdR.  Therefore,  the effect of BUdR  on /~m appeared  to be relatively 
selective and not due to a mechanism affecting all membrane proteins. 
In support of the latter proposal (b) are the biochemical data on/~ chain synthesis 
in control and BUdR-treated cells. Separation of total #  chains from control, surface 
/~+ B cell lines revealed two distinct bands; the larger molecule co-migrated with 125I- 
labeled  membrane  /~  on  SDS-PAGE.  BUdR-treated  cultures,  however,  produced 
almost entirely the smaller (73 kd)/~ chain. To evaluate whether this smaller/~ was a 
precursor to ~  and differed simply because of glycosylation (11,  39), we evaluated/1 
chains produced by control and BUdR-treated cells that were labeled in the presence 
of tunicamycin  (36).  Again, two unglycosylated/~ chains were discernible in control 
cultures,  and  only the  smaller/~ chain  band could be isolated  from BUdR-treated 
cells.  Thus,  treatment  with  BUdR  inhibited  synthesis,  and  not  merely insertion  of 
membrane IgM. Secretory IgM production was unaffected by BUdR. 
Because the messenger RNA for/~s and/~m are produced by alternative splicing of 
the same/~ gene (15,  38), it is consistent with these data that the effect of BUdR on 
surface IgM expression is due to interference with /~m RNA processing but not with 
/~  RNA.  In  fact,  processing of/~s  RNA  may increase  in  these  lines  after /~m RNA 
processing is blocked. By two separate methods, we found total IgM production to be 
unaffected after surface IgM expression was blocked. Although there is an increase in 
~s production after ~m synthesis is blocked by BUdR, actual secretion of ~  chains in 
these cell lines is not greatly increased. This finding is not surprising because a  well- 
developed microsomal system is necessary for active secretion of virtually any mole- 
cule,  which  BUdR-treated  B  lymphocyte lines  may lack.  Further,  combination  of 
heavy chains with light chains (40) and J  chains (41-43) are also important factors in 
determining  whether  an  Ig heavy chain  is  secreted.  Of note  in  this  regard  is  the 
observation that  secretory/~ chains  can be synthesized by "pre-B cell" hybridomas 
and  cell  lines  without  significant  quantities  of/~  being  secreted  into  the  culture 
medium  (44).  Therefore,  a  switch  from /~r, processing  to  /~  processing  would  not 
necessarily result  in an increase in IgM secretion.  Studies  are underway to examine 
the size and type of/~ gene transcript produced in BUdR-treated cells. 
The  observation  that  inhibition  of gm  synthesis  and  expression  is  reversible  in 
BUdR-treated  B  lymphoblastoid  cells  is  important.  It  strongly  implies  that  the 
mechanisms for regulating the processing of/~ chain mRNA can be switched reversibly. 
The ability to switch  mRNA processing from/~ to/~m would  be necessary if pre-B 
cells initially synthesize ~  after V-D-J-C joining (4).  Secretory Ig heavy chains might 
then be synthesized by all cells in the B lineage because they are found even in surface 
Ig  + B lymphocytes (11,  39).  Regulation of mRNA processing during differentiation 
would  primarily  involve  formation  of membrane /~  message, either  stimulating  its 
appearance during differentiation from a pre-B to B cell or suppressing its production 
during differentiation  from a  B  cell to plasma cell.  Active secretion of Ig molecules 
would necessitate production of secretory type Ig heavy chains, light chains, possibly 
J  chains, and a well formed endoplasmic reticulum--Golgi complex. 
The site of action of BUdR remains unclear. Because it has been previously reported LINDA HENDERSHOT AND DANIEL LEVITT  1631 
that low doses of BUdR primarily inhibit "luxury" or differentiation-specific macro- 
molecule  expression  in  many  cell  types  without  interfering  with  normal  cellular 
functions (24, 25), it is unusual that this molecule does not simply halt the production 
of Ig by cells in the B lineage. Most studies indicate that DNA synthesis (and therefore 
incorporation of BUdR into the genome) is required for BUdR to exert its effect (26, 
45).  For membrane #  to be produced,  the  5' end  of the membrane exon must  be 
spliced to a 3' exon of the #  gene that is distinct from the 3' terminus of/~ (15).  It is 
possible that BUdR is incorporated into thymidine-rich areas flanking the/tin exon. 
Resulting changes in these pyrimidine nucleosides might interfere with the adenyla- 
tion or splicing of the membrane/~ exon. Such alterations could lead to the loss  of 
/~ RNA production. Alternatively, BUdR may act by changing the production of a 
splice-adenylation regulator for #m mRNA at a site relatively distant from the # gene 
(15, 46). By selectively discriminating between the formation of secretory and mem- 
brane/~, BUdR will be a useful probe for examining the molecular regulation of these 
two  forms  of heavy chains  during  development,  especially when  combined  with 
techniques of gene cloning and sequencing. 
Summary 
Regulation  of membrane  and  secretory  #  synthesis  was  examined  in  human 
lymphoblastoid cell lines representing various stages of differentiation. Immunoglob- 
ulin  phenotype was  determined  by surface  and  cytoplasmic staining  with  fluoro- 
chrome-conjugated  antibodies  and  by  sodium  dodecyl  sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) analysis of anti-/t precipitable cellular products. 
The thymidine analogue, 5-bromo-2'-deoxyuridine (BUdR), which inhibits differ- 
entiation-specific proteins in a  variety of systems, was used to examine regulation of 
immunoglobulin synthesis. We found that BUdR had a  differential effect on mem- 
brane ~m) and secretory (/&) type # heavy chains. Ig production in pre-B and plasma 
cell-like lines, which make/&, was unaffected by BUdR. However, surface expression 
of IgM (/~) in B cell lines was drastically inhibited at similar doses of BUdR without 
diminishing total Ig or protein synthesis. Examination of labeled # chains from control 
and BUdR-treated B cell lines by SDS-PAGE revealed the production of two sizes of 
/1 (,urn and/&) in control cells and only the smaller size ~s) in BUdR-treated cells. This 
size difference could not be attributed to alterations in glycosylation of the molecules. 
These data show that BUdR inhibits the production of membrane/z chains without 
diminishing secretory #  chain synthesis in  the same cell.  Our  findings suggest  that 
thymidine-rich regions of the genome are involved in the regulation of/zm vs./zs during 
B cell differentiation. 
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